Home Home Home Inbox Home Search

Event

Clinical Experience with Telavancin for the Treatment of Monomicrobial Staphylococcus Aureus Lower Respiratory Tract Infections in Patients: Final Results from the Telavancin Observational Use Registry (TOUR™) [Board No. P457]

Location: Board no. P457
Session Type: Thematic Poster Session
Monday
May
21
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Anna Osmukhina

PhD
Theravance Biopharma US Inc.

Ryan K. Shields

PharmD
University of of Pittsburgh

Dino Delaportas

MD
Mountaineer Infectious Disease LLC

Candice Clay

PhD
Theravance Biopharma US Inc.

Bibiana Castaneda-Ruiz

MD
Theravance Biopharma US Inc.

Ziba Ansari-Orlando

PharmD
Marin General Hospital

View Abstract

Clinical Experience with Telavancin for the Treatment of Monomicrobial Staphylococcus Aureus Lower Respiratory Tract Infections in Patients: Final Results from the Telavancin Observational Use Registry (TOUR™)

Parent Sessions

  • B42 - CRITICAL CARE: THE FEVER - INFECTIONS IN THE ICU...
    05-21-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search